Loading...
Loading...
India's erythromycin imports from UNITED STATES total $337.8K across 60 shipments from 15 foreign suppliers. TEVA EDISON PACKAGING leads with $77.1K in import value; the top 5 suppliers together control 81.0% of this origin. Leading Indian buyers include ACTAVIS PHARMA DEVELOPMENT CENTRE PRIVATE LIMITED. This corridor reflects India's pharmaceutical import demand for erythromycin — a diversified sourcing base with multiple active suppliers from UNITED STATES.

TEVA EDISON PACKAGING is the leading Erythromycin supplier from UNITED STATES to India, with import value of $77.1K across 4 shipments. The top 5 suppliers — TEVA EDISON PACKAGING, JUPITER RESEARCH SERVICES INC, ACTAVIS LABORATORIES FL INC, ESPEE BIOPHARMA & FINECHEM LLC, AGRACE PHARMA — collectively account for 81.0% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | TEVA EDISON PACKAGING | $77.1K | 4 | 22.8% |
| 2 | JUPITER RESEARCH SERVICES INC | $75.7K | 1 | 22.4% |
| 3 | ACTAVIS LABORATORIES FL INC | $74.9K | 4 | 22.2% |
| 4 | ESPEE BIOPHARMA & FINECHEM LLC | $23.8K | 5 | 7.0% |
| 5 | AGRACE PHARMA | $22.1K | 3 | 6.5% |
| 6 | NEW LIFE MEDICALS USA INC | $20.3K | 1 | 6.0% |
| 7 | Good Health Pharma Supplies | $18.2K | 3 | 5.4% |
| 8 | ACTAVIS LABORATORIES FL INC. | $7.2K | 10 | 2.1% |
| 9 | AMNEAL PHARMACEUTICALS OF LLC | $6.3K | 8 | 1.9% |
| 10 | United States Pharmacopeial Convention | $3.4K | 2 | 1.0% |
| 11 | HOSPIRA A PFIZER COMPANY... | $2.9K | 2 | 0.9% |
| 12 | QUANTIME WORLD INC | $2.0K | 2 | 0.6% |
| 13 | MS NEWLIFE MEDICALS (USA).INC. | $1.1K | 1 | 0.3% |
| 14 | TOLMAR | $949 | 1 | 0.3% |
| 15 | MORTON GROVE PHARMACEUTICALS | $747 | 1 | 0.2% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | ACTAVIS PHARMA DEVELOPMENT CENTRE PRIVATE LIMITED | $159.3K | 18 | 47.1% |
| 2 | MICRO LABS LIMITED | $114.7K | 3 | 33.9% |
| 3 | AJANTA PHARMA LIMITED | $22.1K | 3 | 6.5% |
| 4 | HETERO LABS LIMITED | $18.2K | 3 | 5.4% |
| 5 | AMNEAL PHARMACEUTICALS PRIVATE LIMITED | $6.3K | 8 | 1.9% |
| 6 | AUROBINDO PHARMA LTD | $5.2K | 4 | 1.5% |
| 7 | NOVITIUM LABS PRIVATE LIMITED | $3.5K | 11 | 1.0% |
| 8 | PFIZER HEALTHCARE INDIA PRIVATE LIMITED | $2.9K | 2 | 0.9% |
| 9 | TOPIOX RESEARCH CENTRE PRIVATE LIMITED | $2.0K | 2 | 0.6% |
| 10 | GLAND PHARMA LIMITED | $1.1K | 1 | 0.3% |
| 11 | ENCUBE ETHICALS PRIVATE LIMITED | $949 | 1 | 0.3% |
| 12 | WOCKHARDT LIMITED | $747 | 1 | 0.2% |
| 13 | AUROBINDO PHARMA LIMITED | $654 | 1 | 0.2% |
| 14 | ALEMBIC PHARMACEUTICALS LIMITED | $266 | 1 | 0.1% |
| 15 | 3CUBE MEDICARE PRIVATE LIMITED | $2 | 1 | 0.0% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Erythromycin suppliers from UNITED STATES to India include TEVA EDISON PACKAGING, JUPITER RESEARCH SERVICES INC, ACTAVIS LABORATORIES FL INC. The leading supplier is TEVA EDISON PACKAGING with import value of $77.1K USD across 4 shipments. India imported Erythromycin worth $337.8K USD from UNITED STATES in total across 60 shipments.
India imported Erythromycin worth $337.8K USD from UNITED STATES across 60 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Erythromycin sourced from UNITED STATES include ACTAVIS PHARMA DEVELOPMENT CENTRE PRIVATE LIMITED, MICRO LABS LIMITED, AJANTA PHARMA LIMITED. The largest buyer is ACTAVIS PHARMA DEVELOPMENT CENTRE PRIVATE LIMITED with $159.3K in imports across 18 shipments.
The total value of Erythromycin imports from UNITED STATES to India is $337.8K USD, across 60 shipments and 15 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
60 Verified Shipments
15 suppliers, 15 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists